<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font29">the </span>
   <span class="font21">liver </span>
   <span class="font19">with </span>
   <span class="font17">hepatitis </span>
   <span class="font16">g/d) </span>
   <span class="font16">hepatoprotective </span>
   <span class="font15">was </span>
   <span class="font15">patients </span>
   <span class="font14">TBIL </span>
   <span class="font14">{background </span>
   <span class="font14">were </span>
   <span class="font14">ALT, </span>
   <span class="font13">agents </span>
   <span class="font13">chronic </span>
   <span class="font13">acid </span>
   <span class="font13">al. </span>
   <span class="font13">treatment </span>
   <span class="font13">fibrosis </span>
   <span class="font13">that </span>
   <span class="font13">The </span>
   <span class="font13">margin </span>
   <span class="font13">AST, </span>
   <span class="font13">{border-style </span>
   <span class="font12">clinical </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">antiviral </span>
   <span class="font12">(WMD </span>
   <span class="font12">UDCA </span>
   <span class="font12">[-., </span>
   <span class="font12">effects </span>
   <span class="font12">two </span>
   <span class="font12">ALT </span>
   <span class="font12">agent </span>
   <span class="font12">controlled </span>
   <span class="font12">ursodeoxycholic </span>
   <span class="font12">(). </span>
   <span class="font12">-.; </span>
   <span class="font12">model </span>
   <span class="font12">single </span>
   <span class="font12">vs. </span>
   <span class="font11">randomized </span>
   <span class="font11">trials </span>
   <span class="font11">Hepatoprotective </span>
   <span class="font11">Silibinin </span>
   <span class="font11">silibinin </span>
   <span class="font11">Data </span>
   <span class="font11">Figure </span>
   <span class="font11">are </span>
   <span class="font11">combination </span>
   <span class="font11">levels </span>
   <span class="font11">one </span>
   <span class="font11">showed </span>
   <span class="font11">using </span>
   <span class="font11">GGT, </span>
   <span class="font11">Hepatitis </span>
   <span class="font11">NAC </span>
   <span class="font11">combined </span>
   <span class="font11">drug </span>
   <span class="font11">drugs </span>
   <span class="font11">efficacy </span>
   <span class="font11">hepatic </span>
   <span class="font11">studies </span>
   <span class="font11">than </span>
   <span class="font11">HA, </span>
   <span class="font11">Meta-Analysis </span>
   <span class="font11">cell </span>
   <span class="font11">function </span>
   <span class="font11">may </span>
   <span class="font11">protective </span>
   <span class="font11">reported </span>
   <span class="font11">significant </span>
   <span class="font11">used </span>
   <span class="font11">(Figure </span>
   <span class="font11">-.]), </span>
   <span class="font11">Med </span>
   <span class="font11">With </span>
   <span class="font11">acetylcysteine </span>
   <span class="font11">confidence </span>
   <span class="font11">current </span>
   <span class="font11">for </span>
   <span class="font11">other </span>
   <span class="font11">px; </span>
   <span class="font11">treat </span>
   <span class="font11">{font-family </span>
   <span class="font11">ALP </span>
   <span class="font11">ALP, </span>
   <span class="font11">Agents </span>
   <span class="font11">Forest </span>
   <span class="font11">Liver </span>
   <span class="font11">PIIIP </span>
   <span class="font11">Plots </span>
   <span class="font11">compared </span>
   <span class="font11">font-size </span>
   <span class="font11">group </span>
   <span class="font11">infection </span>
   <span class="font11">pooled </span>
   <span class="font11">presented </span>
   <span class="font11">reduce </span>
   <span class="font11">study </span>
   <span class="font11">terms </span>
   <span class="font11">used. </span>
   <span class="font10">(Table </span>
   <span class="font10">Effects </span>
   <span class="font10">LN, </span>
   <span class="font10">Placebo </span>
   <span class="font10">between </span>
   <span class="font10">can </span>
   <span class="font10">cirrhosis </span>
   <span class="font10">difference </span>
   <span class="font10">disease </span>
   <span class="font10">double; </span>
   <span class="font10">effect </span>
   <span class="font10">heterogeneity </span>
   <span class="font10">mean </span>
   <span class="font10">promote </span>
   <span class="font10">serum </span>
   <span class="font10">severe </span>
   <span class="font10">statistically </span>
   <span class="font10">therapy </span>
   <span class="font10">treated </span>
   <span class="font10">versus </span>
   <span class="font10">which </span>
   <span class="font10">AST </span>
   <span class="font10">Basic </span>
   <span class="font10">IV-C </span>
   <span class="font10">Med. </span>
   <span class="font10">Meta-analysis </span>
   <span class="font10">basic </span>
   <span class="font10">bile </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">effective </span>
   <span class="font10">improve </span>
   <span class="font10">indexes </span>
   <span class="font10">injection </span>
   <span class="font10">intervals. </span>
   <span class="font10">more </span>
   <span class="font10">qod </span>
   <span class="font10">random-effects </span>
   <span class="font10">silymarin </span>
   <span class="font10">solid; </span>
   <span class="font10">subjects </span>
   <span class="font10">subjects, </span>
   <span class="font10">test </span>
   <span class="font10">three </span>
   <span class="font10">viral </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">&amp;gt; </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">(No. </span>
   <span class="font10">(unclear) </span>
   <span class="font10">-., </span>
   <span class="font10">.]) </span>
   <span class="font10">Funnel </span>
   <span class="font10">Group </span>
   <span class="font10">HBV </span>
   <span class="font10">Lamivudine </span>
   <span class="font10">Levels </span>
   <span class="font10">N-acetylcysteine </span>
   <span class="font10">Patients </span>
   <span class="font10">Results </span>
   <span class="font10">TBIL, </span>
   <span class="font10">agent. </span>
   <span class="font10">better </span>
   <span class="font10">biliary </span>
   <span class="font10">bold </span>
   <span class="font10">control </span>
   <span class="font10">courier; </span>
   <span class="font10">course </span>
   <span class="font10">em; </span>
   <span class="font10">evaluate </span>
   <span class="font10">fibrosis, </span>
   <span class="font10">from </span>
   <span class="font10">groups </span>
   <span class="font10">included </span>
   <span class="font10">including </span>
   <span class="font10">indicators </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">mg/d </span>
   <span class="font10">million </span>
   <span class="font10">normalization </span>
   <span class="font10">only </span>
   <span class="font10">plot </span>
   <span class="font10">primary </span>
   <span class="font10">pt;} </span>
   <span class="font10">recovery </span>
   <span class="font10">significantly </span>
   <span class="font10">superior </span>
   <span class="font10">total </span>
  </p>
 </body>
</html>
